DIY sperm test to hit the market this fall
By Meghana Keshavan,
STAT News
| 06. 20. 2016
A semen centrifuge is the newest direct-to-consumer fertility device on the market. The Trak, a desktop gadget that measures a man’s sperm count, was approved by the Food and Drug Administration earlier this month for consumer use.
The device, developed by Bay Area startup Sandstone Diagnostics, runs on AA batteries, costs $159.99, and even syncs with your phone. It’s slated to ship directly to consumers this fall.
Men use a dropper to deposit a sample of their ejaculate into a small well in the device. Powered by a small motor, the Trak quickly spins the semen so that the sperm cells settle on the bottom. The device then simply gauges the level of sperm cells in the sample.
Continue reading on STAT News
Image via Flickr
Related Articles
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...
By Beth Duff-Brown, Stanford Institute for Economic Policy Research | 07.12.2024
The debate over in vitro fertilization (IVF) has become a hot-button policy and political issue, despite the medical procedure to help people become pregnant having been mainstream in the United States for nearly half a century.
The Alabama Supreme Court ...
